Showing 1,501 - 1,520 results of 108,744 for search '(( 1 point decrease ) OR ( 5 ((nn decrease) OR (((we decrease) OR (a decrease)))) ))', query time: 1.64s Refine Results
  1. 1501
  2. 1502
  3. 1503
  4. 1504
  5. 1505
  6. 1506
  7. 1507
  8. 1508
  9. 1509
  10. 1510

    Strains used in this study. by Xin Zhou (54275)

    Published 2024
    “…This is the first known example of point mutations causing azole tolerance in <i>C</i>. …”
  11. 1511

    Primers used in this study. by Xin Zhou (54275)

    Published 2024
    “…This is the first known example of point mutations causing azole tolerance in <i>C</i>. …”
  12. 1512
  13. 1513
  14. 1514
  15. 1515
  16. 1516
  17. 1517
  18. 1518

    Data extraction grid. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  19. 1519

    Incidence rates of AOM cases. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”
  20. 1520

    Inclusion criteria. by Heloisa Ricci Conesa (18291210)

    Published 2024
    “…No homogenous trends were identified in incidence rates across countries, or in detection of S. pneumoniae as a cause of AOM over time. There were indications of a reduction in hospitalization rates (decreases between 24.5–38.8% points, depending on country, PCV type and time since PCV introduction) and antibiotic resistance (decreases between 14–24%, depending on country), following the widespread use of PCVs over time. …”